Illness insight and neurophysiological error-processing deficits in schizophrenia.

Abstract:

:Impaired illness insight in schizophrenia is associated with non-adherence and worse outcomes. Schizophrenia patients also exhibit error-monitoring deficits, which have been proposed to cause poor insight. To test this hypothesis, we examined whether schizophrenia patients' deficits in neurophysiological error-monitoring indices, the error-related negativity (ERN) and error positivity (Pe) event-related potential (ERP) amplitudes, are associated with impaired insight. ERPs were recorded in 18 schizophrenia patients and 18 normal comparison participants during a Stroop task. Patients' subnormal ERN and Pe amplitudes did not correlate with insight, suggesting that impaired insight in schizophrenia stems from neurocognitive mechanisms other than deficient error monitoring.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Kansal V,Patriciu I,Kiang M

doi

10.1016/j.schres.2014.03.023

subject

Has Abstract

pub_date

2014-06-01 00:00:00

pages

122-7

issue

1

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(14)00149-2

journal_volume

156

pub_type

杂志文章
  • The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions.

    abstract:OBJECTIVE:The aim of this study was to test the goodness-of-fit of all previously published five-factor models of the Positive and Negative Syndrome Scale (PANSS). METHODS:We used confirmatory factor analysis (CFA) with a large data set (N = 5769). RESULTS:The different subsamples were tested for heterogeneity and we...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.04.001

    authors: van der Gaag M,Cuijpers A,Hoffman T,Remijsen M,Hijman R,de Haan L,van Meijel B,van Harten PN,Valmaggia L,de Hert M,Wiersma D

    更新日期:2006-07-01 00:00:00

  • Natural surroundings in childhood are associated with lower schizophrenia rates.

    abstract::High exposure to green space and natural environments has previously been associated with lower schizophrenia rates possibly through low air pollution and improved psychological restoration. Exposure to natural environments could explain the negative urban-rural gradient of schizophrenia, but it is unclear if all natu...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.10.012

    authors: Engemann K,Svenning JC,Arge L,Brandt J,Geels C,Mortensen PB,Plana-Ripoll O,Tsirogiannis C,Pedersen CB

    更新日期:2020-02-01 00:00:00

  • The efficacy of supported employment for middle-aged and older people with schizophrenia.

    abstract:OBJECTIVE:Supported employment is the evidence-based treatment of choice for assisting individuals with severe mental illness to achieve competitive employment, but few supported employment programs specifically target older clients with psychiatric illness. The purpose of this study was to evaluate the efficacy of sup...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2011.11.036

    authors: Twamley EW,Vella L,Burton CZ,Becker DR,Bell MD,Jeste DV

    更新日期:2012-03-01 00:00:00

  • Regional differences in expression of β-tubulin isoforms in schizophrenia.

    abstract::A growing body of evidence suggests that abnormal elements of the cytoskeleton may be associated with the pathophysiology of schizophrenia. Isoforms of a major cytoskeleton protein, β-tubulin, were recently demonstrated to have distinct roles in neuronal differentiation and cell viability. For these reasons, we tested...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.12.010

    authors: Moehle MS,Luduena RF,Haroutunian V,Meador-Woodruff JH,McCullumsmith RE

    更新日期:2012-03-01 00:00:00

  • Neurocognitive impairment across the lifespan in schizophrenia: an update.

    abstract::A literature review and power analysis of longitudinal studies published since 1997 investigating the trajectory of neurocognitive deficits across time in patients with schizophrenia was conducted. Ten studies were identified, evaluating a total of 834 patients with mean ages of 24.0-77.8 years at study entry. Power e...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2004.07.005

    authors: Kurtz MM

    更新日期:2005-04-01 00:00:00

  • High dose D-serine in the treatment of schizophrenia.

    abstract:BACKGROUND:D-serine is an allosteric modulator of the brain N-methyl-d-aspartate (NMDA) receptor and a potential novel treatment of schizophrenia. Double-blind studies have been performed at 30 mg/kg/day (approximately 2 g/day) with encouraging results, but no formal dose escalation studies have been performed. We desc...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.schres.2010.05.012

    authors: Kantrowitz JT,Malhotra AK,Cornblatt B,Silipo G,Balla A,Suckow RF,D'Souza C,Saksa J,Woods SW,Javitt DC

    更新日期:2010-08-01 00:00:00

  • Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

    abstract::Though negative symptoms in schizophrenia are associated with a host of deleterious outcomes (e.g., White et al., 2009), not all individuals with schizophrenia suffer from negative symptoms (e.g., Blanchard et al., 2005). Thus, methods to quickly screen and identify patients for more intensive clinical interview asses...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.12.007

    authors: Park SG,Llerena K,McCarthy JM,Couture SM,Bennett ME,Blanchard JJ

    更新日期:2012-03-01 00:00:00

  • Switch and maintenance of task set in schizophrenia.

    abstract::Task set maintenance and switching deficits are robust in schizophrenia. However, little is known about how these constructs are related to one another. The development of an improved understanding of set switching and maintenance deficits in schizophrenia requires that these constructs be explicated in terms of eleme...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.01.022

    authors: Kieffaber PD,Kappenman ES,Bodkins M,Shekhar A,O'Donnell BF,Hetrick WP

    更新日期:2006-06-01 00:00:00

  • Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing physical activity among individuals with schizophrenia.

    abstract:BACKGROUND:Individuals with schizophrenia tend to have low levels of physical activity (PA) which contributes to high rates of physical comorbidities. Valid and reliable methods of assessing PA are essential for advancing health research. Ten years after initial validation of the Short-Form International Physical Activ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.09.010

    authors: Duncan MJ,Arbour-Nicitopoulos K,Subramanieapillai M,Remington G,Faulkner G

    更新日期:2017-01-01 00:00:00

  • Testing a modification of cognitive adaptation training: streamlining the model for broader implementation.

    abstract::Cognitive adaptation training (CAT) is a home-based, manualized treatment that utilizes environmental supports to improve target behaviors and functional outcomes in persons with schizophrenia. Although clinical trials have shown CAT to be effective across functional, clinical, and treatment adherence domains, when th...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2014.03.026

    authors: Kidd SA,Herman Y,Barbic S,Ganguli R,George TP,Hassan S,McKenzie K,Maples N,Velligan D

    更新日期:2014-06-01 00:00:00

  • A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up.

    abstract::Meta-analyses of randomized controlled trials support the efficacy of cognitive behavioral therapy (CBT) in the treatment of symptoms of schizophrenia refractory to antipsychotic medication. This article addresses the issue of medium term durability. A five-year follow-up was undertaken of a sample of 90 subjects who ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2007.09.026

    authors: Turkington D,Sensky T,Scott J,Barnes TR,Nur U,Siddle R,Hammond K,Samarasekara N,Kingdon D

    更新日期:2008-01-01 00:00:00

  • The neurobiology of relapse in schizophrenia.

    abstract::Dopamine's proposed role in psychosis proved a starting point in our understanding of the neurobiology of relapse, fitting given the central role positive symptoms play. This link is reflected in early work examining neurotransmitter metabolite and drug (e.g. amphetamine, methylphenidate) challenge studies as a means ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2013.10.009

    authors: Remington G,Foussias G,Agid O,Fervaha G,Takeuchi H,Hahn M

    更新日期:2014-02-01 00:00:00

  • Computational approaches to schizophrenia: A perspective on negative symptoms.

    abstract::Schizophrenia is a heterogeneous spectrum disorder often associated with detrimental negative symptoms. In recent years, computational approaches to psychiatry have attracted growing attention. Negative symptoms have shown some overlap with general cognitive impairments and were also linked to impaired motivational pr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2016.10.004

    authors: Deserno L,Heinz A,Schlagenhauf F

    更新日期:2017-08-01 00:00:00

  • Challenging the need for sustained blockade of dopamine D₂ receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study.

    abstract:OBJECTIVE:Blockade of dopamine D₂ receptors with antipsychotics above 65% is associated with optimal chance of clinical response although recent data suggest a lower threshold for the maintenance treatment of schizophrenia. The objective of this study was to prospectively examine whether such continuous high blockade w...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2015.03.025

    authors: Tsuboi T,Suzuki T,Bies RR,Remington G,Pollock BG,Mimura M,Uchida H

    更新日期:2015-05-01 00:00:00

  • The nuts and bolts of Cognitive Remediation: Exploring how different training components relate to cognitive and functional gains.

    abstract:BACKGROUND:Cognitive Remediation (CR) is an evidence based treatment targeting cognitive and functional difficulties in people with psychosis. Despite the large number of effectiveness studies, only limited evidence exists for the active ingredients of this therapy. This study begins to fill this gap by exploring the r...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2017.09.012

    authors: Cella M,Wykes T

    更新日期:2019-01-01 00:00:00

  • Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.

    abstract::Treatments for cognitive and functional impairments associated with severe mental illnesses are urgently needed. We tested a 12-week, manualized, Compensatory Cognitive Training (CCT) intervention targeting prospective memory, attention, learning/memory, and executive functioning in the context of supported employment...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2017.08.005

    authors: Twamley EW,Thomas KR,Burton CZ,Vella L,Jeste DV,Heaton RK,McGurk SR

    更新日期:2019-01-01 00:00:00

  • Natural killer cell activity in schizophrenia and schizoaffective disorder: a pilot study.

    abstract::Natural killer cell activity was prospectively studied in 15 patients with chronic schizophrenia and in seven patients with schizoaffective disorder, depressed type. These patients were compared to individually matched normal controls. No mean differences in natural killer cell activity between the patient groups and ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(92)90028-4

    authors: McDaniel JS,Jewart RD,Eccard MB,Pollard WE,Caudle J,Stipetic M,Risby ED,Lewine R,Risch SC

    更新日期:1992-12-01 00:00:00

  • Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300.

    abstract::Abnormality of P300 waveforms of event-related potentials (ERPs) has been suggested to represent an aspect of the pathophysiology of schizophrenia. Previous work points to the contribution of altered neural function in discrete brain regions in the left hemisphere to psychotic symptoms and cognitive deficits of schizo...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.01.020

    authors: Higuchi Y,Sumiyoshi T,Kawasaki Y,Matsui M,Arai H,Kurachi M

    更新日期:2008-04-01 00:00:00

  • Basic self-disturbances independently predict recovery in psychotic disorders: A seven year follow-up study.

    abstract:BACKGROUND:Recovery is the ultimate goal of psychosis treatment. Basic self-disturbances (BSDs) are non-psychotic phenomena associated with clinical outcome, present in prodromal, psychotic and residual phases of psychotic disorders. AIM:To investigate the relationship between BSDs and recovery seven years after first...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.08.009

    authors: Svendsen IH,Øie MG,Møller P,Nelson B,Haug E,Melle I

    更新日期:2019-10-01 00:00:00

  • Paranoid schizophrenia and methamphetamine-induced paranoia are both characterized by a similar LINE-1 partial methylation profile, which is more pronounced in paranoid schizophrenia.

    abstract:BACKGROUND:There is evidence that schizophrenia is a neuro-immune disorder. Genes linked to intragenic LINE-1 methylation show a strong association with immune-associated disorders including psychosis. The aim of this study was to examine LINE-1 methylation patterns in paranoid schizophrenia and methamphetamine-induced...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.02.015

    authors: Kalayasiri R,Kraijak K,Mutirangura A,Maes M

    更新日期:2019-06-01 00:00:00

  • Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137.

    abstract::MicroRNAs (miRNAs) are small non-coding RNAs that mainly function as negative regulators of gene expression (Lai, 2002) and have been shown to be involved in schizophrenia etiology through genetic and expression studies (Burmistrova et al., 2007; Hansen et al., 2007a; Perkins et al., 2007; Beveridge et al., 2010; Kim ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.06.038

    authors: Kim AH,Parker EK,Williamson V,McMichael GO,Fanous AH,Vladimirov VI

    更新日期:2012-10-01 00:00:00

  • Longitudinal investigation of the relationship between family history of psychosis and affective disorders and Child Behavior Checklist ratings in clinical high-risk adolescents.

    abstract::This is the first study to investigate whether positive family history (FH) of psychosis and affective disorders moderates the relationship between child diagnostic status and parent-reported social and behavioral problems on the Child Behavior Checklist (CBCL) in clinical high-risk adolescents. This longitudinal inve...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.04.027

    authors: Simeonova DI,Lee FJ,Walker EF

    更新日期:2015-08-01 00:00:00

  • Do schizophrenia and affective disorder share susceptibility genes?

    abstract::Schizophrenia and affective disorders are relatively common neuropsychiatric diseases with a complex genetic etiology. A multigenic inheritance with variable influence of unknown environmental factors may be involved. Family studies have demonstrated the existence of both phenotypes in the same kindreds, and in certai...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/s0920-9964(99)00108-5

    authors: Wildenauer DB,Schwab SG,Maier W,Detera-Wadleigh SD

    更新日期:1999-09-29 00:00:00

  • A meta-analysis of emotion perception and functional outcomes in schizophrenia.

    abstract:INTRODUCTION:Emotion perception (EP) is impaired in schizophrenia, is stable across clinical state, resistant to antipsychotic treatment and linked to symptom severity. Given its pervasive nature, there is a need to quantitatively examine whether this dysfunction impacts functional outcomes. We used a meta-analytic str...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.schres.2012.01.023

    authors: Irani F,Seligman S,Kamath V,Kohler C,Gur RC

    更新日期:2012-05-01 00:00:00

  • Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats.

    abstract::Astrocytic markers glial fibrillary acidic protein (GFAP) and connexin 43 (CX43) are known to have altered expression in brains of subjects with psychiatric disorders including autism and major depression. The current study investigated whether GFAP and CX43 expressions are affected by several commonly used psychotrop...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.05.016

    authors: Fatemi SH,Folsom TD,Reutiman TJ,Pandian T,Braun NN,Haug K

    更新日期:2008-09-01 00:00:00

  • Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial.

    abstract:BACKGROUND:Individuals at ultra-high risk (UHR) for psychosis have significant cognitive deficits that can impede functional recovery. Applying cognitive remediation (CR) before the onset of frank psychosis may improve the cognitive and functional prognosis of UHR individuals, however, little is known about the feasibi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2020.08.016

    authors: Glenthøj LB,Mariegaard LS,Fagerlund B,Jepsen JRM,Kristensen TD,Wenneberg C,Krakauer K,Medalia A,Roberts DL,Hjorthøj C,Nordentoft M

    更新日期:2020-10-01 00:00:00

  • Mental health multimorbidity and poor quality of life in patients with schizophrenia.

    abstract:OBJECTIVE:While "dual diagnosis" involving both psychiatric and substance use disorders has long been a focus of schizophrenia research, recent studies have advocated for a shift of focus to multimorbidity, addressing comorbidity from both additional psychiatric disorders and substance use disorders. We hypothesized th...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2018.04.035

    authors: Bhalla IP,Stefanovics EA,Rosenheck RA

    更新日期:2018-11-01 00:00:00

  • Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

    abstract::We have previously reported aberrations in the striatal presynaptic dopamine function in neuroleptic-naive schizophrenic patients compared to healthy controls (Hietala, J., Syvälahti, E., Vuorio, K. et al., 1995. Lancet 346, 1130-1131). In this extended study we explore whether the altered presynaptic dopamine functio...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(98)00113-3

    authors: Hietala J,Syvälahti E,Vilkman H,Vuorio K,Räkköläinen V,Bergman J,Haaparanta M,Solin O,Kuoppamäki M,Eronen E,Ruotsalainen U,Salokangas RK

    更新日期:1999-01-04 00:00:00

  • Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.

    abstract::A recent systematic review concluded that cannabis use increases risk of psychotic outcomes independently of confounding and transient intoxication effects. Furthermore, a model of the association between cannabis use and schizophrenia indicated that the incidence and prevalence of schizophrenia would increase from 19...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.05.031

    authors: Frisher M,Crome I,Martino O,Croft P

    更新日期:2009-09-01 00:00:00

  • A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.

    abstract::Schizophrenia is associated with significant impairments in both higher and lower order social cognitive performance and these impairments contribute to poor social functioning. People with schizophrenia report poor social functioning to be one of their greatest unmet treatment needs. Recent studies have suggested the...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2015.06.005

    authors: Guastella AJ,Ward PB,Hickie IB,Shahrestani S,Hodge MA,Scott EM,Langdon R

    更新日期:2015-11-01 00:00:00